Receipt dates: January 5, April 5, September 5
Expires on January 6, 2020
This targeted funding opportunity is for projects that focus on developing next-generation technologies and tools to better define cell heterogeneity and organization rules. The goal of the funding opportunity is to accelerate the edvelopment and translation of the cutting-edge single cell analysis approaches.
Applications can propose high-impact technologies that include but are not limited to:
Although applications will not be restricted to a particular type of technology, NIH is especially interested in applications to develop next-generation approaches that can or have the potential to distinguish heterogeneous states among cells in situ or in clinically relevant samples.
In addition, NCI is especially interested in applications for novel tools/technologies that enable the characterization of this heterogeneity among cells in situ or in clinically relevant samples and for clinically testing drug combinations and resistance with minimal invasiveness. These tools/technologies include but are not limited to multidimensional single cell imaging, single cell mass cytometry, high throughput technologies for isolation and characterization of DNA and RNA from individual cells either in situ or in clinically relevant samples.
For more information about this funding opportunity, please contact NCI SBIR Program Director Jian Lou (email@example.com).